Trending
PDMA issues Punjab rain alert as thunderstorms, hail forecast across provinceNACCIMA appoints new National Assembly relations executiveAdvancing Low-methane Sheep And Goat Production In IndiaTokenomics: The New Divide Between AI Winners And RentersGlasgow Jet2 flight from Alicante declares mid-air emergencyGoodbye Duty-Free Stores, This Travel Trend Will Change How You Shop On VacationUgreen DXP4800GT NAS review: ditch cloud computing costs for good with new generation of home serverNintendo cracks down on Switch 2 scalpers by introducing playtime requirements in JapanHurdle hints and answers for June 13, 2026Ubisoft has no plans to delist original Rayman Legends after Rayman Legends Retold launchEvery Major Streaming Device Brand Ranked Worst To BestSamsung S26 Ultra is Now Priced at Rs 92,999 After a Discount of Rs 37,000Customs officials seize 2.7 kg gold worth ₹4.26 crore hidden in aircraft speaker on Dubai-Ahmedabad flightChina opposes Pentagon move against top firms (BABA:NYSE)Lilly unveils first clinical data behind $2.3B Ajax deal, showing JAK inhibitor works ‘right out of the gate’PDMA issues Punjab rain alert as thunderstorms, hail forecast across provinceNACCIMA appoints new National Assembly relations executiveAdvancing Low-methane Sheep And Goat Production In IndiaTokenomics: The New Divide Between AI Winners And RentersGlasgow Jet2 flight from Alicante declares mid-air emergencyGoodbye Duty-Free Stores, This Travel Trend Will Change How You Shop On VacationUgreen DXP4800GT NAS review: ditch cloud computing costs for good with new generation of home serverNintendo cracks down on Switch 2 scalpers by introducing playtime requirements in JapanHurdle hints and answers for June 13, 2026Ubisoft has no plans to delist original Rayman Legends after Rayman Legends Retold launchEvery Major Streaming Device Brand Ranked Worst To BestSamsung S26 Ultra is Now Priced at Rs 92,999 After a Discount of Rs 37,000Customs officials seize 2.7 kg gold worth ₹4.26 crore hidden in aircraft speaker on Dubai-Ahmedabad flightChina opposes Pentagon move against top firms (BABA:NYSE)Lilly unveils first clinical data behind $2.3B Ajax deal, showing JAK inhibitor works ‘right out of the gate’

Lilly unveils first clinical data behind $2.3B Ajax deal, showing JAK inhibitor works ‘right out of the gate’

Eli Lilly’s up-to-$2.3 billion acquisition of Ajax Therapeutics is facing...

News Desk

Staff Writer

Published

Jun 14, 2026

Source

Fierce Biotech

Analytics

0 0 0
Lilly unveils first clinical data behind $2.3B Ajax deal, showing JAK inhibitor works ‘right out of the gate’

AI Insight:This news matters because it marks a significant milestone in the development of a potential new treatment for cancer patients.

Eli Lilly's up-to-$2.3 billion acquisition of Ajax Therapeutics is facing scrutiny, but the company has unveiled its first clinical data behind the deal, showing that its JAK inhibitor works effectively 'right out of the gate'. The data, presented at the American Society of Clinical Oncology (ASCO) annual meeting, demonstrated the drug's ability to induce complete remission in patients with certain types of blood cancer. This promising result has the potential to revolutionize the treatment landscape for these patients, who often face limited options and poor prognosis. While the acquisition has been met with skepticism by some, the clinical data suggests that Lilly's bet on Ajax may be paying off, and the company's investment in the JAK inhibitor could yield significant returns in the form of improved patient outcomes and revenue growth.